Anti-idiotype RNAs that mimic the leucine-rich nuclear export signal and specifically bind to CRM1/exportin 1

Chemistry and Biology

Volumn 7, Issue 5, 2000, Pages 345-354

  Hamm, Jörg ^a   Fornerod, Maarten ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

HIV 1 Rev; NES recognition domain; Nuclear export; RNA mimicry

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; NES;

EID: 0034111062     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(00)00112-5     Document Type: Article

References (38)

1. Davis L.I. The nuclear pore complex. Annu. Rev. Biochem. 64:1995;865-896.
2. Doye V., Hurt E. From nuclear porins to the nuclear pore complexes. Curr. Opin. Cell Biol. 9:1997;401-411.
3. Mattaj I.W., Englmeier L. Nucleocytoplasmic transport: the soluble phase. Annu. Rev. Biochem. 67:1998;265-306.
4. Fornerod M., Grosveld G.et al. The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88. EMBO J. 16:1997;807-816.
5. Görlich D., Izaurralde E.et al. A novel class of RanGTP binding proteins. J. Cell Biol. 138:1997;65-80.
6. Dahlberg J.E., Lund E. Functions of the GTPase Ran in RNA export from the nucleus. Curr. Opin. Cell. Biol. 3:1998;400-408.
7. Fornerod M., Ohno M., Yoshida M., Mattaj I.W. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell. 90:1997;1051-1060.
8. Fukuda M., Nishida E.et al. CRM1 is responsible for intracellular transport mediated by the nuclear export signal. Nature. 390:1997;308-311.
9. Neville M., Stutz F., Lee L., Davis L.I., Rosbash M. The importin-β family member CRM1 bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr. Biol. 7:1997;767-775.
10. Stade K., Ford C.S., Guthrie C., Weiss K. Exportin1 (CRM1) is an essential nuclear export factor. Cell. 90:1997;1041-1050.
11. Pollard V.W., Malim M.H. The HIV-1 REV protein. Annu. Rev. Microbiol. 52:1998;491-532.
12. Malim M.H., Böhnlein J., Hauber J., Cullen B.R. Functional dissection of the HIV-1 Rev trans-activator-derivation of a trans-dominant repressor of Rev function. Cell. 58:1989;205-214.
13. Malim M.H., McCarn D.F., Tiley L.S., Cullen B.R. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J. Virol. 65:1991;4248-4252.
14. Bogerd H.P., Echarri A., Ross T.M., Cullen B.R. Inhibition of human immunodeficiency virus Rev and human T-cell leuckemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to CRM1. J. Virol. 72:1998;8627-8635.
15. Kudo N., Yoshida M.et al. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242:1998;540-547.
16. Askjaer P., Jensen T.H., Nilsson J., Englmeier L., Kjems J. The specificity of the CRM1-Rev nuclear export signal interaction is mediated by RanGTP. J. Biol. Chem. 273:1998;33414-33422.
17. Ellington A.D., Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature. 346:1990;818-822.
18. Gold L., Polisky B., Uhlenbeck O., Yarus M. Diversity of oligonucleotide functions. Annu. Rev. Biochem. 64:1994;763-797.
19. Joyce G.F. In vitro evolution of nucleic acids. Curr. Opin. Struct. Biol. 4:1994;331-336.
20. Kenan D.J., Tsai D.E., Keene J.D. Exploring the molecular diversity with combinatorial shape libraries. Trends Biochem. Sci. 19:1994;57-64.
21. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 249:1990;505-510.
22. Wilson C., Szostak J.W. In vitro selection of functional nucleic acids. Annu. Rev. Biochem. 68:1999;611-647.
23. Hamm J., Huber J., Lührmann R. Anti-idiotype RNA selected with an anti-nuclear export signal antibody is actively transported in oocytes and inhibits Rev- and cap-dependent RNA export. Proc. Natl Acad. Sci. USA. 94:1997;12839-12844.
24. Fischer U., Huber J., Boelens W.C., Mattaj I.W., Lührmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell. 82:1995;475-483.
25. Sundquist W.I., Heaphy S. Evidence for interstrand quadruplex formation in the dimerization of human immunodeficiency virus 1 genomic RNA. Proc. Natl Acad. Sci. USA. 90:1993;3393-3397.
26. Wolff B., Sanglier J.J., Wang Y. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. Chem. Biol. 4:1997;139-147.
27. Nishi K., Yoshida M., Fujiwara D., Nishikawa M., Horinouchi S., Beppu T. Leptomycin B targets a regulatory cascade of CRM1, a fisson yeast nuclear protein, involved in control of higher order chromosome structure and gene expression. J. Biol. Chem. 269:1994;6320-6324.
28. Neville M., Rosbash M. The NES-CRM1p export pathway is not a major mRNA export route in Saccharomyces cerevisiae. EMBO J. 18:1999;3746-3756.
29. Kudo N., Horinouchi S.et al. Leptomycin B inactivates CRM1/exportin1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl Acad. Sci. USA. 96:1999;9112-9117.
30. Doudna J.A., Cech T.R., Sullenger B.A. Selection of an RNA molecule that mimics a major autoantigenic epitope of the human insulin receptor. Proc. Natl Acad. Sci. USA. 92:1995;2355-2359.
31. Hamm J. Characterisation of antibody-binding RNAs selected from structurally constrained libraries. Nucleic Acids Res. 24:1996;2220-2227.
32. Tsai D.E., Kenan D.J., Keene J.D. In vitro selection of an RNA epitope immunologically cross-reactive with a peptide. Proc. Natl Acad. Sci. USA. 89:1992;8864-8868.
33. Lee S.W., Sullenger B.A. Isolation of a nuclease-resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes. J. Exp. Med. 184:1996;315-324.
34. Lee S.W., Sullenger B.A. Isolation of nuclease-resistant decoy RNA that can protect human acetylcholine receptors from myasthenic antibodies. Nat. Biotechnol. 15:1997;41-45.
35. Phe, EF-Tu, and a GTP analog. Science. 270:1995;1464-1472.
36. Nyborg J., Clark B.F.C.et al. Structure of the ternary complex of EF-Tu: macromolecular mimicry in translation. Trends Biochem. Sci. 21:1996;81-82.
37. Englmeier L., Olivo J.C., Mattaj I.W. Receptor-mediated substrate translocation through the nuclear pore complex without nucleotide triphosphate hydrolysis. Curr. Biol. 9:1999;30-41.
38. Arts G.J., Fornerod M., Mattaj I.W. Identification of a nuclear export receptor for tRNA. Curr. Biol. 8:1998;305-314.